15m
Assessing Intellia Therapeutics (NTLA) Valuation After FDA Lifts Clinical Hold On Key Phase 3 Trial
FDA decision reshapes the near term picture for Intellia Therapeutics (NTLA) The FDA’s decision to lift its clinical hold on Intellia Therapeutics’ MAGNITUDE-2 Phase 3 trial for nexiguran ziclumeran ...
The White House launched Project Vault, a US$12b program to build a US strategic stockpile of critical minerals. USA Rare Earth (NasdaqGM:USAR) is positioned as a potential supplier into this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results